a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis

Abstract

The study's objective was to create a proniosomal carrier system that would effectively transport the entrapped medication over a prolonged period of time in order to treat hypertension.Method: Proniosomes were used to encapsulate captopril in different proniosomal gel formulations made of different ratios of sorbitan fatty acid esters, cholesterol, and lecithin that were prepared using the coacervation-phase separation method in order to explore the drug's potential as a transdermal drug delivery system. Size, vesicle count, drug entrapment, drug release patterns, and vesicular stability under various storage settings were all measured in vitro for the developed systems. For four weeks, proniosomal gel stability investigations were conducted.Results: 66.7 - 78.7% of the encapsulated material was produced using the proniosome loading technique.Transmission electron microscopy was used to characterize protoniosomes. In vitro research revealed a delayed release of captopril that was entrapped. Higher drug retention was seen under cold settings.In conclusion, our research clearly shows that proniosomes have a fair amount of stability and are a viable long-term delivery strategy for captopril.